Triveni Bio Inc., a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders, announced a...
n-Lorem, a nonprofit foundation, announced that Ultragenyx has continued its partnership with n-Lorem and provided a second donation to support n-Lorem’s efforts to discover,...
Synthego, the genome engineering company, announced it has raised $200 million of growth capital, including a Series E financing led by Perceptive Advisors. Also...
The Center for Breakthrough Medicines (CBM) and the University of Pennsylvania's Gene Therapy Program (GTP) have signed a landmark collaboration agreement, to combine Penn's...
IASO Biotherapeutics, a clinical-stage biopharmaceutical company focused on discovering, developing, and manufacturing innovative medicines and Innovent Biologics, Inc., a world-class biopharmaceutical company that develops,...
